▶ 調査レポート

口蹄疫(FMD)ワクチンの世界市場(~2026年)

• 英文タイトル:Global Foot and Mouth Disease (FMD) Vaccine Market Insights and Forecast to 2026

QYResearchが調査・発行した産業分析レポートです。口蹄疫(FMD)ワクチンの世界市場(~2026年) / Global Foot and Mouth Disease (FMD) Vaccine Market Insights and Forecast to 2026 / MRC2-11QY06460資料のイメージです。• レポートコード:MRC2-11QY06460
• 出版社/出版日:QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、115ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療、製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は口蹄疫(FMD)ワクチンのグローバル市場について調査・分析したレポートです。種類別(従来ワクチン、緊急ワクチン)市場規模、用途別(牛、羊、山羊、豚、カモシカ、鹿、バイソン、ラクダ)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別口蹄疫(FMD)ワクチンの競争状況、市場シェア
・世界の口蹄疫(FMD)ワクチン市場:種類別市場規模 2015年-2020年(従来ワクチン、緊急ワクチン)
・世界の口蹄疫(FMD)ワクチン市場:種類別市場規模予測 2021年-2026年(従来ワクチン、緊急ワクチン)
・世界の口蹄疫(FMD)ワクチン市場:用途別市場規模 2015年-2020年(牛、羊、山羊、豚、カモシカ、鹿、バイソン、ラクダ)
・世界の口蹄疫(FMD)ワクチン市場:用途別市場規模予測 2021年-2026年(牛、羊、山羊、豚、カモシカ、鹿、バイソン、ラクダ)
・北米の口蹄疫(FMD)ワクチン市場分析:米国、カナダ
・ヨーロッパの口蹄疫(FMD)ワクチン市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの口蹄疫(FMD)ワクチン市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の口蹄疫(FMD)ワクチン市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの口蹄疫(FMD)ワクチン市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Agrovet market、Biogénesis Bago、Vecol、FGBI - Federal Centre for Animal Health、Indian Immunologicals、Merial、VSVRI、FMD Center、Limor de Colombia
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

An drug that provide immunity to the FMD.
Growing livestock population and increasing demand for animal products are some of the factors contributing to the increased adoption of these vaccines globally. Livestock and zoonotic diseases are increasing over the past few decades owing to factors such as adverse climatic transformations and rapid globalization.

Market Analysis and Insights: Global Foot and Mouth Disease (FMD) Vaccine Market
The global Foot and Mouth Disease (FMD) Vaccine market size is projected to reach US$ 966.4 million by 2026, from US$ 875.6 million in 2020, at a CAGR of 9.6%% during 2021-2026.

Global Foot and Mouth Disease (FMD) Vaccine Scope and Market Size
Foot and Mouth Disease (FMD) Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Foot and Mouth Disease (FMD) Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Foot and Mouth Disease (FMD) Vaccine market is segmented into
Conventional Vaccines
Emergency Vaccines

Segment by Application, the Foot and Mouth Disease (FMD) Vaccine market is segmented into
Cattle
Sheep and goat
Pigs
Antelope
Deer
Bison
Camelids

Regional and Country-level Analysis
The Foot and Mouth Disease (FMD) Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Foot and Mouth Disease (FMD) Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Foot and Mouth Disease (FMD) Vaccine Market Share Analysis
Foot and Mouth Disease (FMD) Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Foot and Mouth Disease (FMD) Vaccine business, the date to enter into the Foot and Mouth Disease (FMD) Vaccine market, Foot and Mouth Disease (FMD) Vaccine product introduction, recent developments, etc.

The major vendors covered:
Agrovet market
Biogénesis Bago
Vecol
FGBI – Federal Centre for Animal Health
Indian Immunologicals
Merial
VSVRI
FMD Center
Limor de Colombia

レポート目次

1 Study Coverage
1.1 Foot and Mouth Disease (FMD) Vaccine Product Introduction
1.2 Market Segments
1.3 Key Foot and Mouth Disease (FMD) Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Foot and Mouth Disease (FMD) Vaccine Market Size Growth Rate by Type
1.4.2 Conventional Vaccines
1.4.3 Emergency Vaccines
1.5 Market by Application
1.5.1 Global Foot and Mouth Disease (FMD) Vaccine Market Size Growth Rate by Application
1.5.2 Cattle
1.5.3 Sheep and goat
1.5.4 Pigs
1.5.5 Antelope
1.5.6 Deer
1.5.7 Bison
1.5.8 Camelids
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Foot and Mouth Disease (FMD) Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Foot and Mouth Disease (FMD) Vaccine Revenue 2015-2026
2.1.2 Global Foot and Mouth Disease (FMD) Vaccine Sales 2015-2026
2.2 Global Foot and Mouth Disease (FMD) Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Foot and Mouth Disease (FMD) Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Foot and Mouth Disease (FMD) Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Foot and Mouth Disease (FMD) Vaccine Competitor Landscape by Players
3.1 Foot and Mouth Disease (FMD) Vaccine Sales by Manufacturers
3.1.1 Foot and Mouth Disease (FMD) Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Foot and Mouth Disease (FMD) Vaccine Revenue by Manufacturers
3.2.1 Foot and Mouth Disease (FMD) Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Foot and Mouth Disease (FMD) Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Foot and Mouth Disease (FMD) Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Foot and Mouth Disease (FMD) Vaccine Revenue in 2019
3.2.5 Global Foot and Mouth Disease (FMD) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Foot and Mouth Disease (FMD) Vaccine Price by Manufacturers
3.4 Foot and Mouth Disease (FMD) Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Foot and Mouth Disease (FMD) Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Foot and Mouth Disease (FMD) Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Foot and Mouth Disease (FMD) Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Foot and Mouth Disease (FMD) Vaccine Market Size by Type (2015-2020)
4.1.1 Global Foot and Mouth Disease (FMD) Vaccine Sales by Type (2015-2020)
4.1.2 Global Foot and Mouth Disease (FMD) Vaccine Revenue by Type (2015-2020)
4.1.3 Foot and Mouth Disease (FMD) Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Foot and Mouth Disease (FMD) Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Foot and Mouth Disease (FMD) Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Foot and Mouth Disease (FMD) Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Foot and Mouth Disease (FMD) Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Foot and Mouth Disease (FMD) Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Foot and Mouth Disease (FMD) Vaccine Market Size by Application (2015-2020)
5.1.1 Global Foot and Mouth Disease (FMD) Vaccine Sales by Application (2015-2020)
5.1.2 Global Foot and Mouth Disease (FMD) Vaccine Revenue by Application (2015-2020)
5.1.3 Foot and Mouth Disease (FMD) Vaccine Price by Application (2015-2020)
5.2 Foot and Mouth Disease (FMD) Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Foot and Mouth Disease (FMD) Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Foot and Mouth Disease (FMD) Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Foot and Mouth Disease (FMD) Vaccine Price Forecast by Application (2021-2026)

6 North America
6.1 North America Foot and Mouth Disease (FMD) Vaccine by Country
6.1.1 North America Foot and Mouth Disease (FMD) Vaccine Sales by Country
6.1.2 North America Foot and Mouth Disease (FMD) Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Foot and Mouth Disease (FMD) Vaccine Market Facts & Figures by Type
6.3 North America Foot and Mouth Disease (FMD) Vaccine Market Facts & Figures by Application

7 Europe
7.1 Europe Foot and Mouth Disease (FMD) Vaccine by Country
7.1.1 Europe Foot and Mouth Disease (FMD) Vaccine Sales by Country
7.1.2 Europe Foot and Mouth Disease (FMD) Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Foot and Mouth Disease (FMD) Vaccine Market Facts & Figures by Type
7.3 Europe Foot and Mouth Disease (FMD) Vaccine Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccine by Region
8.1.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccine Sales by Region
8.1.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Foot and Mouth Disease (FMD) Vaccine Market Facts & Figures by Application

9 Latin America
9.1 Latin America Foot and Mouth Disease (FMD) Vaccine by Country
9.1.1 Latin America Foot and Mouth Disease (FMD) Vaccine Sales by Country
9.1.2 Latin America Foot and Mouth Disease (FMD) Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Foot and Mouth Disease (FMD) Vaccine Market Facts & Figures by Type
9.3 Central & South America Foot and Mouth Disease (FMD) Vaccine Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccine by Country
10.1.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Sales by Country
10.1.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Market Facts & Figures by Application

11 Company Profiles
11.1 Agrovet market
11.1.1 Agrovet market Corporation Information
11.1.2 Agrovet market Description and Business Overview
11.1.3 Agrovet market Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Agrovet market Foot and Mouth Disease (FMD) Vaccine Products Offered
11.1.5 Agrovet market Related Developments
11.2 Biogénesis Bago
11.2.1 Biogénesis Bago Corporation Information
11.2.2 Biogénesis Bago Description and Business Overview
11.2.3 Biogénesis Bago Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Biogénesis Bago Foot and Mouth Disease (FMD) Vaccine Products Offered
11.2.5 Biogénesis Bago Related Developments
11.3 Vecol
11.3.1 Vecol Corporation Information
11.3.2 Vecol Description and Business Overview
11.3.3 Vecol Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Vecol Foot and Mouth Disease (FMD) Vaccine Products Offered
11.3.5 Vecol Related Developments
11.4 FGBI – Federal Centre for Animal Health
11.4.1 FGBI – Federal Centre for Animal Health Corporation Information
11.4.2 FGBI – Federal Centre for Animal Health Description and Business Overview
11.4.3 FGBI – Federal Centre for Animal Health Sales, Revenue and Gross Margin (2015-2020)
11.4.4 FGBI – Federal Centre for Animal Health Foot and Mouth Disease (FMD) Vaccine Products Offered
11.4.5 FGBI – Federal Centre for Animal Health Related Developments
11.5 Indian Immunologicals
11.5.1 Indian Immunologicals Corporation Information
11.5.2 Indian Immunologicals Description and Business Overview
11.5.3 Indian Immunologicals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccine Products Offered
11.5.5 Indian Immunologicals Related Developments
11.6 Merial
11.6.1 Merial Corporation Information
11.6.2 Merial Description and Business Overview
11.6.3 Merial Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Merial Foot and Mouth Disease (FMD) Vaccine Products Offered
11.6.5 Merial Related Developments
11.7 VSVRI
11.7.1 VSVRI Corporation Information
11.7.2 VSVRI Description and Business Overview
11.7.3 VSVRI Sales, Revenue and Gross Margin (2015-2020)
11.7.4 VSVRI Foot and Mouth Disease (FMD) Vaccine Products Offered
11.7.5 VSVRI Related Developments
11.8 FMD Center
11.8.1 FMD Center Corporation Information
11.8.2 FMD Center Description and Business Overview
11.8.3 FMD Center Sales, Revenue and Gross Margin (2015-2020)
11.8.4 FMD Center Foot and Mouth Disease (FMD) Vaccine Products Offered
11.8.5 FMD Center Related Developments
11.9 Limor de Colombia
11.9.1 Limor de Colombia Corporation Information
11.9.2 Limor de Colombia Description and Business Overview
11.9.3 Limor de Colombia Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Limor de Colombia Foot and Mouth Disease (FMD) Vaccine Products Offered
11.9.5 Limor de Colombia Related Developments
11.1 Agrovet market
11.1.1 Agrovet market Corporation Information
11.1.2 Agrovet market Description and Business Overview
11.1.3 Agrovet market Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Agrovet market Foot and Mouth Disease (FMD) Vaccine Products Offered
11.1.5 Agrovet market Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Foot and Mouth Disease (FMD) Vaccine Market Estimates and Projections by Region
12.1.1 Global Foot and Mouth Disease (FMD) Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Foot and Mouth Disease (FMD) Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Foot and Mouth Disease (FMD) Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Foot and Mouth Disease (FMD) Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Foot and Mouth Disease (FMD) Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Foot and Mouth Disease (FMD) Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Foot and Mouth Disease (FMD) Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Foot and Mouth Disease (FMD) Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Foot and Mouth Disease (FMD) Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Foot and Mouth Disease (FMD) Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Foot and Mouth Disease (FMD) Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Foot and Mouth Disease (FMD) Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Foot and Mouth Disease (FMD) Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Foot and Mouth Disease (FMD) Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Foot and Mouth Disease (FMD) Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Foot and Mouth Disease (FMD) Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Foot and Mouth Disease (FMD) Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Foot and Mouth Disease (FMD) Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Foot and Mouth Disease (FMD) Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Foot and Mouth Disease (FMD) Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Foot and Mouth Disease (FMD) Vaccine Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Foot and Mouth Disease (FMD) Vaccine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Foot and Mouth Disease (FMD) Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Foot and Mouth Disease (FMD) Vaccine Market Segments
Table 2. Ranking of Global Top Foot and Mouth Disease (FMD) Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Foot and Mouth Disease (FMD) Vaccine Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Conventional Vaccines
Table 5. Major Manufacturers of Emergency Vaccines
Table 6. Global Foot and Mouth Disease (FMD) Vaccine Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Foot and Mouth Disease (FMD) Vaccine Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Foot and Mouth Disease (FMD) Vaccine Sales by Regions 2015-2020 (K Units)
Table 9. Global Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Regions (2015-2020)
Table 10. Global Foot and Mouth Disease (FMD) Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Foot and Mouth Disease (FMD) Vaccine Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Foot and Mouth Disease (FMD) Vaccine Sales Share by Manufacturers (2015-2020)
Table 13. Global Foot and Mouth Disease (FMD) Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Foot and Mouth Disease (FMD) Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Foot and Mouth Disease (FMD) Vaccine as of 2019)
Table 15. Foot and Mouth Disease (FMD) Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Foot and Mouth Disease (FMD) Vaccine Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Foot and Mouth Disease (FMD) Vaccine Price (2015-2020) (USD/Unit)
Table 18. Foot and Mouth Disease (FMD) Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Foot and Mouth Disease (FMD) Vaccine Product Type
Table 20. Date of International Manufacturers Enter into Foot and Mouth Disease (FMD) Vaccine Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Foot and Mouth Disease (FMD) Vaccine Sales by Type (2015-2020) (K Units)
Table 23. Global Foot and Mouth Disease (FMD) Vaccine Sales Share by Type (2015-2020)
Table 24. Global Foot and Mouth Disease (FMD) Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Foot and Mouth Disease (FMD) Vaccine Revenue Share by Type (2015-2020)
Table 26. Foot and Mouth Disease (FMD) Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Foot and Mouth Disease (FMD) Vaccine Sales by Application (2015-2020) (K Units)
Table 28. Global Foot and Mouth Disease (FMD) Vaccine Sales Share by Application (2015-2020)
Table 29. North America Foot and Mouth Disease (FMD) Vaccine Sales by Country (2015-2020) (K Units)
Table 30. North America Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Country (2015-2020)
Table 31. North America Foot and Mouth Disease (FMD) Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Country (2015-2020)
Table 33. North America Foot and Mouth Disease (FMD) Vaccine Sales by Type (2015-2020) (K Units)
Table 34. North America Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Type (2015-2020)
Table 35. North America Foot and Mouth Disease (FMD) Vaccine Sales by Application (2015-2020) (K Units)
Table 36. North America Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Application (2015-2020)
Table 37. Europe Foot and Mouth Disease (FMD) Vaccine Sales by Country (2015-2020) (K Units)
Table 38. Europe Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Country (2015-2020)
Table 39. Europe Foot and Mouth Disease (FMD) Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Country (2015-2020)
Table 41. Europe Foot and Mouth Disease (FMD) Vaccine Sales by Type (2015-2020) (K Units)
Table 42. Europe Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Type (2015-2020)
Table 43. Europe Foot and Mouth Disease (FMD) Vaccine Sales by Application (2015-2020) (K Units)
Table 44. Europe Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Foot and Mouth Disease (FMD) Vaccine Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Foot and Mouth Disease (FMD) Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Foot and Mouth Disease (FMD) Vaccine Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Foot and Mouth Disease (FMD) Vaccine Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Application (2015-2020)
Table 53. Latin America Foot and Mouth Disease (FMD) Vaccine Sales by Country (2015-2020) (K Units)
Table 54. Latin America Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Foot and Mouth Disease (FMD) Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Country (2015-2020)
Table 57. Latin America Foot and Mouth Disease (FMD) Vaccine Sales by Type (2015-2020) (K Units)
Table 58. Latin America Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Type (2015-2020)
Table 59. Latin America Foot and Mouth Disease (FMD) Vaccine Sales by Application (2015-2020) (K Units)
Table 60. Latin America Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Application (2015-2020)
Table 69. Agrovet market Corporation Information
Table 70. Agrovet market Description and Major Businesses
Table 71. Agrovet market Foot and Mouth Disease (FMD) Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Agrovet market Product
Table 73. Agrovet market Recent Development
Table 74. Biogénesis Bago Corporation Information
Table 75. Biogénesis Bago Description and Major Businesses
Table 76. Biogénesis Bago Foot and Mouth Disease (FMD) Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Biogénesis Bago Product
Table 78. Biogénesis Bago Recent Development
Table 79. Vecol Corporation Information
Table 80. Vecol Description and Major Businesses
Table 81. Vecol Foot and Mouth Disease (FMD) Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Vecol Product
Table 83. Vecol Recent Development
Table 84. FGBI - Federal Centre for Animal Health Corporation Information
Table 85. FGBI - Federal Centre for Animal Health Description and Major Businesses
Table 86. FGBI - Federal Centre for Animal Health Foot and Mouth Disease (FMD) Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. FGBI - Federal Centre for Animal Health Product
Table 88. FGBI - Federal Centre for Animal Health Recent Development
Table 89. Indian Immunologicals Corporation Information
Table 90. Indian Immunologicals Description and Major Businesses
Table 91. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Indian Immunologicals Product
Table 93. Indian Immunologicals Recent Development
Table 94. Merial Corporation Information
Table 95. Merial Description and Major Businesses
Table 96. Merial Foot and Mouth Disease (FMD) Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Merial Product
Table 98. Merial Recent Development
Table 99. VSVRI Corporation Information
Table 100. VSVRI Description and Major Businesses
Table 101. VSVRI Foot and Mouth Disease (FMD) Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. VSVRI Product
Table 103. VSVRI Recent Development
Table 104. FMD Center Corporation Information
Table 105. FMD Center Description and Major Businesses
Table 106. FMD Center Foot and Mouth Disease (FMD) Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. FMD Center Product
Table 108. FMD Center Recent Development
Table 109. Limor de Colombia Corporation Information
Table 110. Limor de Colombia Description and Major Businesses
Table 111. Limor de Colombia Foot and Mouth Disease (FMD) Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Limor de Colombia Product
Table 113. Limor de Colombia Recent Development
Table 114. Global Foot and Mouth Disease (FMD) Vaccine Sales Forecast by Regions (2021-2026) (K Units)
Table 115. Global Foot and Mouth Disease (FMD) Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 116. Global Foot and Mouth Disease (FMD) Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 117. Global Foot and Mouth Disease (FMD) Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 118. North America: Foot and Mouth Disease (FMD) Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 119. North America: Foot and Mouth Disease (FMD) Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Europe: Foot and Mouth Disease (FMD) Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 121. Europe: Foot and Mouth Disease (FMD) Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Asia Pacific: Foot and Mouth Disease (FMD) Vaccine Sales Forecast by Region (2021-2026) (K Units)
Table 123. Asia Pacific: Foot and Mouth Disease (FMD) Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 124. Latin America: Foot and Mouth Disease (FMD) Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 125. Latin America: Foot and Mouth Disease (FMD) Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Middle East and Africa: Foot and Mouth Disease (FMD) Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 127. Middle East and Africa: Foot and Mouth Disease (FMD) Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 129. Key Challenges
Table 130. Market Risks
Table 131. Main Points Interviewed from Key Foot and Mouth Disease (FMD) Vaccine Players
Table 132. Foot and Mouth Disease (FMD) Vaccine Customers List
Table 133. Foot and Mouth Disease (FMD) Vaccine Distributors List
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Foot and Mouth Disease (FMD) Vaccine Product Picture
Figure 2. Global Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Conventional Vaccines Product Picture
Figure 4. Emergency Vaccines Product Picture
Figure 5. Global Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Application in 2020 & 2026
Figure 6. Cattle
Figure 7. Sheep and goat
Figure 8. Pigs
Figure 9. Antelope
Figure 10. Deer
Figure 11. Bison
Figure 12. Camelids
Figure 13. Foot and Mouth Disease (FMD) Vaccine Report Years Considered
Figure 14. Global Foot and Mouth Disease (FMD) Vaccine Market Size 2015-2026 (US$ Million)
Figure 15. Global Foot and Mouth Disease (FMD) Vaccine Sales 2015-2026 (K Units)
Figure 16. Global Foot and Mouth Disease (FMD) Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Region (2015-2020)
Figure 18. Global Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Region in 2019
Figure 19. Global Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Region (2015-2020)
Figure 20. Global Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Region in 2019
Figure 21. Global Foot and Mouth Disease (FMD) Vaccine Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Foot and Mouth Disease (FMD) Vaccine Revenue in 2019
Figure 23. Foot and Mouth Disease (FMD) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Type (2015-2020)
Figure 25. Global Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Type in 2019
Figure 26. Global Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Type (2015-2020)
Figure 27. Global Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Type in 2019
Figure 28. Global Foot and Mouth Disease (FMD) Vaccine Market Share by Price Range (2015-2020)
Figure 29. Global Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Application (2015-2020)
Figure 30. Global Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Application in 2019
Figure 31. Global Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Application (2015-2020)
Figure 32. Global Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Application in 2019
Figure 33. North America Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 34. North America Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Country in 2019
Figure 36. North America Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Country in 2019
Figure 37. U.S. Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 38. U.S. Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 40. Canada Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Foot and Mouth Disease (FMD) Vaccine Market Share by Type in 2019
Figure 42. North America Foot and Mouth Disease (FMD) Vaccine Market Share by Application in 2019
Figure 43. Europe Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 44. Europe Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Country in 2019
Figure 46. Europe Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Country in 2019
Figure 47. Germany Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 48. Germany Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 50. France Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 52. U.K. Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 54. Italy Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 56. Russia Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Foot and Mouth Disease (FMD) Vaccine Market Share by Type in 2019
Figure 58. Europe Foot and Mouth Disease (FMD) Vaccine Market Share by Application in 2019
Figure 59. Asia Pacific Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 60. Asia Pacific Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Region in 2019
Figure 62. Asia Pacific Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Region in 2019
Figure 63. China Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 64. China Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 66. Japan Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 68. South Korea Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 70. India Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 72. Australia Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 74. Taiwan Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 76. Indonesia Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 78. Thailand Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 80. Malaysia Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 82. Philippines Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 84. Vietnam Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Foot and Mouth Disease (FMD) Vaccine Market Share by Type in 2019
Figure 86. Asia Pacific Foot and Mouth Disease (FMD) Vaccine Market Share by Application in 2019
Figure 87. Latin America Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 88. Latin America Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Country in 2019
Figure 90. Latin America Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Country in 2019
Figure 91. Mexico Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 92. Mexico Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 94. Brazil Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 96. Argentina Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Foot and Mouth Disease (FMD) Vaccine Market Share by Type in 2019
Figure 98. Latin America Foot and Mouth Disease (FMD) Vaccine Market Share by Application in 2019
Figure 99. Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 100. Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Revenue Market Share by Country in 2019
Figure 103. Turkey Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 104. Turkey Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 106. Saudi Arabia Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 108. U.A.E Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Market Share by Type in 2019
Figure 110. Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Market Share by Application in 2019
Figure 111. North America Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. North America Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Europe Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Asia Pacific Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Latin America Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Middle East and Africa Foot and Mouth Disease (FMD) Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed